- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Transition Therapeutics Inc+ Add to Watchlist
TTHI:US6.5800 USD 0.0101 0.15%
As of 20:10:00 ET on 07/11/2014.
Company Profile for Transition Therapeutics Inc (TTHI)
Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.
Transition Therapeutics Inc
Key Executives for Transition Therapeutics Inc (TTHI)
|Tony F CruzChairman/CEO||Nicole Rusaw GeorgeChief Financial Officer|
|Carl DamianiChief Operating Officer||Aleksandra PastrakVP:Clinical Dev/Medical Ofcr|
|Bruce ConnopVP:Non-Clinical & Pharma Dev||Louis AlexopoulosSecretary|